eicosapentaenoic acid ethyl ester has been researched along with Atrial Fibrillation in 2 studies
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olshansky, B | 1 |
| Bhatt, DL | 1 |
| Miller, M | 1 |
| Steg, PG | 1 |
| Brinton, EA | 1 |
| Jacobson, TA | 1 |
| Ketchum, SB | 1 |
| Doyle, RT | 1 |
| Juliano, RA | 1 |
| Jiao, L | 1 |
| Kowey, PR | 1 |
| Reiffel, JA | 1 |
| Tardif, JC | 1 |
| Ballantyne, CM | 1 |
| Chung, MK | 1 |
| Sheikh, O | 1 |
| Vande Hei, AG | 1 |
| Battisha, A | 1 |
| Hammad, T | 1 |
| Pham, S | 1 |
| Chilton, R | 1 |
1 review available for eicosapentaenoic acid ethyl ester and Atrial Fibrillation
| Article | Year |
|---|---|
Cardiovascular, electrophysiologic, and hematologic effects of omega-3 fatty acids beyond reducing hypertriglyceridemia: as it pertains to the recently published REDUCE-IT trial.
Topics: Atrial Fibrillation; Biomarkers; Cardiovascular Diseases; Dietary Supplements; Down-Regulation; Eico | 2019 |
1 trial available for eicosapentaenoic acid ethyl ester and Atrial Fibrillation
| Article | Year |
|---|---|
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT.
Topics: Atrial Fibrillation; Eicosapentaenoic Acid; Humans; Risk Factors; Stroke; Treatment Outcome | 2023 |